Back

Lipoprotein(a) variability: challenging the one-time measurement paradigm in cardiovascular risk assessment

31 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (5) Biomarkers Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marta Catarina Almeida

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

7 More presentations in this session

Presentation thumbnail
Association between carotid intima-media thickness and novel lipid parameters in hypertensive patients
Doctor F. Brucato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Tailoring cardiovascular risk assesment: Vascular ultrasound as an emerging and accesible tool
Doctor A. Velasco (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Patients with high Calcium Scores and Lipoprotein (a) levels are at the highest risk for cardiovascular events
Doctor D. Sa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
The importance of Fibrinogen as a cardiovascular risk factor
Doctor A. Rodrigues (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
The potential role of elevated lipoprotein(a) in the early stages of aortic valve stenosis
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (5)

The Event

Event poster

ESC Congress 2025

31 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Intraindividual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate-risk
thumbnail
Congress Presentation
Is lipoprotein(a) a stable measurement over time?
thumbnail
Congress Presentation
Is a single lipoprotein (a) measurement once in a lifetime sufficient? The results from the STAR-Lp(a) study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources